Candice Willmon
Pfizer (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, Bladder and Urothelial Cancer Treatments, CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Renal cell carcinoma treatment
Most-Cited Works
- → Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy(2009)164 cited
- → Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy(2007)136 cited
- → Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma(2009)111 cited
- → Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors(2008)87 cited
- → Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2(2009)71 cited
- → Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus(2014)71 cited
- → Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer(2008)45 cited
- → Yeast Cytosine Deaminase Mutants with Increased Thermostability Impart Sensitivity to 5-Fluorocytosine(2008)42 cited
- → Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide(2010)32 cited
- → Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility(2023)25 cited